Kenichi Harada

1.2k total citations
31 papers, 1.0k citations indexed

About

Kenichi Harada is a scholar working on Spectroscopy, Molecular Biology and Environmental Chemistry. According to data from OpenAlex, Kenichi Harada has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Spectroscopy, 6 papers in Molecular Biology and 6 papers in Environmental Chemistry. Recurrent topics in Kenichi Harada's work include Mass Spectrometry Techniques and Applications (7 papers), Analytical Chemistry and Chromatography (6 papers) and Aquatic Ecosystems and Phytoplankton Dynamics (6 papers). Kenichi Harada is often cited by papers focused on Mass Spectrometry Techniques and Applications (7 papers), Analytical Chemistry and Chromatography (6 papers) and Aquatic Ecosystems and Phytoplankton Dynamics (6 papers). Kenichi Harada collaborates with scholars based in Japan, Brazil and United States. Kenichi Harada's co-authors include Yoshitomo Ikai, Hisao Oka, Makoto Suzuki, Kiyonaga Fujii, Hideaki Murata, Kenji Matsuura, Makoto Suzuki, Fumio Kondo, Masanao Okumura and Naohisa Ishikawa and has published in prestigious journals such as Analytical Chemistry, Journal of Climate and The Journal of Urology.

In The Last Decade

Kenichi Harada

30 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenichi Harada Japan 12 323 322 319 216 164 31 1.0k
Tsuyoshi Mayumi Japan 10 130 0.4× 293 0.9× 298 0.9× 70 0.3× 143 0.9× 18 670
Laura Grauso Italy 22 428 1.3× 188 0.6× 564 1.8× 200 0.9× 93 0.6× 61 1.4k
Yves François Pouchus France 22 207 0.6× 357 1.1× 349 1.1× 150 0.7× 54 0.3× 46 1.0k
Espen Hansen Norway 24 165 0.5× 303 0.9× 529 1.7× 182 0.8× 53 0.3× 68 1.8k
N. Arpin France 22 175 0.5× 425 1.3× 312 1.0× 92 0.4× 36 0.2× 53 1.4k
Hajime Uchida Japan 21 591 1.8× 79 0.2× 338 1.1× 289 1.3× 46 0.3× 90 1.0k
Thais Guaratini Brazil 16 94 0.3× 70 0.2× 340 1.1× 121 0.6× 112 0.7× 39 1.3k
Luigi Giannetti Italy 19 391 1.2× 226 0.7× 379 1.2× 149 0.7× 211 1.3× 36 1.2k
Rómulo Aráoz France 22 800 2.5× 149 0.5× 642 2.0× 227 1.1× 62 0.4× 57 1.5k
Ian W. Burton Canada 23 588 1.8× 106 0.3× 750 2.4× 211 1.0× 178 1.1× 47 1.5k

Countries citing papers authored by Kenichi Harada

Since Specialization
Citations

This map shows the geographic impact of Kenichi Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenichi Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenichi Harada more than expected).

Fields of papers citing papers by Kenichi Harada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenichi Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenichi Harada. The network helps show where Kenichi Harada may publish in the future.

Co-authorship network of co-authors of Kenichi Harada

This figure shows the co-authorship network connecting the top 25 collaborators of Kenichi Harada. A scholar is included among the top collaborators of Kenichi Harada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenichi Harada. Kenichi Harada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Atsushi, Masanori Abe, Tadashi Namisaki, et al.. (2025). A placebo-controlled Phase 2 trial of E6011, anti-human fractalkine monoclonal antibody, in primary biliary cholangitis. Journal of Translational Autoimmunity. 10. 100283–100283. 3 indexed citations
2.
Minato, Akinori, Toshihisa Tomoda, Hiroyuki Masaoka, et al.. (2024). Clinical Outcomes of Enfortumab Vedotin in Advanced Urothelial Carcinoma With Prior Avelumab Versus Pembrolizumab Therapy. Anticancer Research. 44(8). 3419–3426. 6 indexed citations
3.
Minato, Akinori, et al.. (2023). IMPACT OF ADJUVANT CHEMOTHERAPY AFTER RADICAL CYSTECTOMY FOR PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER. The Japanese Journal of Urology. 114(4). 99–107.
4.
Tomisaki, Ikko, et al.. (2022). Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab. Anticancer Research. 43(1). 269–274. 1 indexed citations
5.
Kinoshita, Masashi, Hemragul Sabit, Tomoyuki Hayashi, et al.. (2022). Non-occlusive mesenteric ischemia during bevacizumab treatment for glioblastoma: a case report. Acta Neurochirurgica. 164(10). 2767–2771. 1 indexed citations
6.
Harada, Kenichi, Yasuko Okamoto, Keiichi Matsuzaki, et al.. (2022). Anchietins A–E: 30-norfriedelane-type triterpenes from Anchietea pyrifolia. Phytochemistry. 203. 113388–113388. 1 indexed citations
7.
Harada, Kenichi, Hideaki Miyake, Sadao Kamidono, & Masato Fujisawa. (2011). 2120 ADDITIONAL SAMPLING OF THE DORSAL APEX ON SYSTEMATIC PROSTATE BIOPSY: IMPACT ON EARLY DETECTION OF PROSTATE CANCER. The Journal of Urology. 185(4S). 2 indexed citations
8.
Mayumi, Tsuyoshi, et al.. (2007). Formation of diagnostic product ions from cyanobacterial cyclic peptides by the two‐bond fission mechanism using ion trap liquid chromatography/multi‐stage mass spectrometry. Rapid Communications in Mass Spectrometry. 21(6). 1025–1033. 12 indexed citations
9.
Itoh, Hisanori & Kenichi Harada. (2004). Coupling between Tropospheric and Stratospheric Leading Modes. Journal of Climate. 17(2). 320–336. 17 indexed citations
11.
Fujii, Kiyonaga, et al.. (2000). ChemInform Abstract: Nontoxic Peptides from Toxic Cyanobacteria, Oscillatoria agardhii.. ChemInform. 31(19). 3 indexed citations
12.
Harada, Kenichi. (1999). Recent Advances of Toxic Cyanobacteria Researches. JOURNAL OF HEALTH SCIENCE. 45(3). 150–165. 26 indexed citations
13.
Oka, Hisao, et al.. (1998). Mass spectrometric analysis of tetracycline antibiotics in foods. Journal of Chromatography A. 812(1-2). 309–319. 62 indexed citations
14.
Zhou, Bingsheng, et al.. (1997). THE PRELIMINARY STUDY OF ENVIRONMENTAL BEHAVIOUR OF MICROCYSTINS. Acta Hydrobiologica Sinica. 21(1). 85–89. 1 indexed citations
15.
Kondo, Fumio, Yoshitomo Ikai, Hisao Oka, et al.. (1992). Formation, characterization, and toxicity of the glutathione and cysteine conjugates of toxic heptapeptide microcystins. Chemical Research in Toxicology. 5(5). 591–596. 179 indexed citations
16.
Ikai, Yoshitomo, Norihisa Kawamura, Junko Hayakawa, et al.. (1991). Purification of food color red no. 106 (acid red) using high-speed counter-current chromatography. Journal of Chromatography A. 538(1). 149–156. 11 indexed citations
17.
Harada, Kenichi, Kiyoshi OGAWA, Kenji Matsuura, et al.. (1990). Structural determination of geometrical isomers of microcystins LR and RR from cyanobacteria by two-dimensional NMR spectroscopic techniques. Chemical Research in Toxicology. 3(5). 473–481. 120 indexed citations
18.
Ikai, Yoshitomo, Hisao Oka, Norihisa Kawamura, et al.. (1989). Improvement of chemical analysis of antibiotics. Journal of Chromatography A. 477(2). 397–406. 38 indexed citations
19.
Harada, Kenichi, Susumu Ito, Naohito Takeda, & Makoto Suzuki. (1983). Structural investigation of the antibiotic sporaviridin. IX. Chemical ionization mass spectral studies of permethylated viridopentaoses and their degradation products.. Chemical and Pharmaceutical Bulletin. 31(11). 3855–3864. 4 indexed citations
20.
Suzuki, Makoto, Kenichi Harada, Naohito Takeda, & Akira Tatematsu. (1981). Chemical Ionization Mass Spectrometry of Macrolide Antibiotics II. Platenomycin and Related Compounds. Heterocycles. 15(2). 1123–1123. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026